Related references
Note: Only part of the references are listed.Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1)
Sven Marcel Schmitt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a
Ning Wang et al.
TUMOR BIOLOGY (2016)
Mechanisms Underlying Lung Resistance-Related Protein (LRP)-Mediated Doxorubicin Resistance of Non-Small Cell Lung Cancer Cells
Yu-Lun Chen et al.
CHINESE JOURNAL OF PHYSIOLOGY (2016)
Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer
Hua Sui et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells
Songhee Han et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27 KIP1 –Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression
Michael J. Thwaites et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1
Hai-Xiang Gao et al.
MOLECULAR MEDICINE REPORTS (2016)
A glutathione S-transferase gene associated with antioxidant properties isolated from Apis cerana cerana
Shuchang Liu et al.
SCIENCE OF NATURE (2016)
20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway
Yi Chen et al.
ONCOLOGY REPORTS (2016)
PIK3CA and PIK3CB silencing by RNAi reverse MDR and inhibit tumorigenic properties in human colorectal carcinoma
Shuhua Wu et al.
TUMOR BIOLOGY (2016)
Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression
Wendian Zhang et al.
ONCOTARGETS AND THERAPY (2016)
Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
Heng Fong Seow et al.
ONCOTARGETS AND THERAPY (2016)
Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
Sahar A. Khaleel et al.
SCIENTIFIC REPORTS (2016)
Ginseng consumption and risk of cancer: A meta-analysis
Xin Jin et al.
JOURNAL OF GINSENG RESEARCH (2016)
Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase
Jianjun Yang et al.
JOURNAL OF GINSENG RESEARCH (2016)
A glutathione S-transferase gene associated with antioxidant properties isolated from Apis cerana cerana
Shuchang Liu et al.
SCIENCE OF NATURE (2016)
BCL-2 inhibition impairs mitochondrial function and targets oral tongue squamous cell carcinoma
Lei Xiong et al.
SPRINGERPLUS (2016)
Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer
Masami Ueda et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy
Elena De Mattia et al.
DRUG RESISTANCE UPDATES (2015)
Gene and protein expression in the oxaliplatin-resistant HT29/L-OHP human colon cancer cell line
Z. Xiang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
20(S)-Ginsenoside Rh2 Induces Apoptosis in Human Leukaemia Reh Cells through Mitochondrial Signaling Pathways
Ting Xia et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Knockdown of EpCAM Enhances the Chemosensitivity of Breast Cancer Cells to 5-fluorouracil by Downregulating the Antiapoptotic Factor Bcl-2
Jiujiao Gao et al.
PLOS ONE (2014)
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
Mariusz Panczyk
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Separation of Ginseng Active Ingredients and their Roles in Cancer Metastasis Supplementary Therapy
Jingjing Xie et al.
CURRENT DRUG METABOLISM (2013)
Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways
Hye-Min Park et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
A dynamic study on reversal of multidrug resistance by ginsenoside Rh2 in adriamycin-resistant human breast cancer MCF-7 cells
Bei Zhou et al.
TALANTA (2012)
Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128
Nan Wu et al.
ACTA PHARMACOLOGICA SINICA (2011)
The in Vitro Structure-Related Anti-Cancer Activity of Ginsenosides and Their Derivatives
Hang Dong et al.
MOLECULES (2011)
Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors
Richard Schwab et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2007)
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy
Frederique Wegran et al.
CLINICAL CANCER RESEARCH (2006)
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models
XW Xie et al.
JOURNAL OF UROLOGY (2006)
Share Paper
